BTNL2 and neoplasm: Notably, in 7 out of 23 samples (no.1, 3, 7, 9, 13, 15 and 20), tumour lesions had significantly higher expression of BTNL2 than did match para-cancerous tissue, while PD-L1 expression showed no difference.